Machine Learning approach to repurpose Azacitidine against Covid-19
Robin Sinha, P Preeti, Trapti Sharma, Kamal Rawal · 2022
Since the outbreak of the coronavirus in 2019, new strains of the virus have evolved and currently, the Omicron (1.1.529) strain has been prevalent and rapidly spreading globally, therefore scientists have been working on developing a novel therapeutic drug that is effective against COVID19. Drug repurposing has been chosen as an emergency alternative due to the lag in typical drug development operations. Its strategy can be broadly categorized into 1) network-based, 2) structure-based, 3) artificial intelligence approaches.